Fecal miR-223 is a noninvasive biomarker for estimating Crohn's disease activity.

Published in: Immunity, inflammation and disease (2024)

Fecal miR-223 might be a novel, noninvasive biomarker for estimating the disease activity of CD patients.

Keyphrases